Application of Transgenic Plants as Production Systems for Pharmaceuticals

G. D. May, Hugh Mason, P. C. Lyons

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Transgenic plants that produce foreign proteins or secondary metabolites with intrinsic industrial or pharmaceutical value represent a cost-effective alternative to fermentation- or organic synthesis-based production systems. There have been a number of recent demonstrations that transgenic plants are capable of producing functional foreign proteins, or that secondary metabolic pathways can be altered for the production of proteins or compounds of known or potential pharmaceutical importance. These examples portend many new and exciting possibilities in the ancient science of plant medicinal chemistry. Here we discuss current progress in the production of phamacologically important proteins and secondary metabolites in transgenic plants.

Original languageEnglish (US)
Pages (from-to)194-204
Number of pages11
JournalACS Symposium Series
Volume647
StatePublished - 1996
Externally publishedYes

Fingerprint

Drug products
Proteins
Metabolites
Pharmaceutical Preparations
Fermentation
Demonstrations
Costs

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Application of Transgenic Plants as Production Systems for Pharmaceuticals. / May, G. D.; Mason, Hugh; Lyons, P. C.

In: ACS Symposium Series, Vol. 647, 1996, p. 194-204.

Research output: Contribution to journalArticle

@article{28d282764ea14194b4157d5e36426b5d,
title = "Application of Transgenic Plants as Production Systems for Pharmaceuticals",
abstract = "Transgenic plants that produce foreign proteins or secondary metabolites with intrinsic industrial or pharmaceutical value represent a cost-effective alternative to fermentation- or organic synthesis-based production systems. There have been a number of recent demonstrations that transgenic plants are capable of producing functional foreign proteins, or that secondary metabolic pathways can be altered for the production of proteins or compounds of known or potential pharmaceutical importance. These examples portend many new and exciting possibilities in the ancient science of plant medicinal chemistry. Here we discuss current progress in the production of phamacologically important proteins and secondary metabolites in transgenic plants.",
author = "May, {G. D.} and Hugh Mason and Lyons, {P. C.}",
year = "1996",
language = "English (US)",
volume = "647",
pages = "194--204",
journal = "ACS Symposium Series",
issn = "0097-6156",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Application of Transgenic Plants as Production Systems for Pharmaceuticals

AU - May, G. D.

AU - Mason, Hugh

AU - Lyons, P. C.

PY - 1996

Y1 - 1996

N2 - Transgenic plants that produce foreign proteins or secondary metabolites with intrinsic industrial or pharmaceutical value represent a cost-effective alternative to fermentation- or organic synthesis-based production systems. There have been a number of recent demonstrations that transgenic plants are capable of producing functional foreign proteins, or that secondary metabolic pathways can be altered for the production of proteins or compounds of known or potential pharmaceutical importance. These examples portend many new and exciting possibilities in the ancient science of plant medicinal chemistry. Here we discuss current progress in the production of phamacologically important proteins and secondary metabolites in transgenic plants.

AB - Transgenic plants that produce foreign proteins or secondary metabolites with intrinsic industrial or pharmaceutical value represent a cost-effective alternative to fermentation- or organic synthesis-based production systems. There have been a number of recent demonstrations that transgenic plants are capable of producing functional foreign proteins, or that secondary metabolic pathways can be altered for the production of proteins or compounds of known or potential pharmaceutical importance. These examples portend many new and exciting possibilities in the ancient science of plant medicinal chemistry. Here we discuss current progress in the production of phamacologically important proteins and secondary metabolites in transgenic plants.

UR - http://www.scopus.com/inward/record.url?scp=1542393495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542393495&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:1542393495

VL - 647

SP - 194

EP - 204

JO - ACS Symposium Series

JF - ACS Symposium Series

SN - 0097-6156

ER -